Management of delayed cerebral ischemia after subarachnoid hemorrhage

被引:0
作者
Charles L. Francoeur
Stephan A. Mayer
机构
[1] CHU de Québec-Université Laval,Critical Care Division, Department of Anesthesiology and Critical Care
[2] Mount Sinai,Department of Neurology (Neurocritical Care)
[3] Icahn School of Medicine at Mount Sinai,Institute for Critical Care Medicine
来源
Critical Care | / 20卷
关键词
Delayed cerebral ischemia; Subarachnoid hemorrhage; Vasospasm; Multimodality monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
For patients who survive the initial bleeding event of a ruptured brain aneurysm, delayed cerebral ischemia (DCI) is one of the most important causes of mortality and poor neurological outcome. New insights in the last decade have led to an important paradigm shift in the understanding of DCI pathogenesis. Large-vessel cerebral vasospasm has been challenged as the sole causal mechanism; new hypotheses now focus on the early brain injury, microcirculatory dysfunction, impaired autoregulation, and spreading depolarization. Prevention of DCI primarily relies on nimodipine administration and optimization of blood volume and cardiac performance. Neurological monitoring is essential for early DCI detection and intervention. Serial clinical examination combined with intermittent transcranial Doppler ultrasonography and CT angiography (with or without perfusion) is the most commonly used monitoring paradigm, and usually suffices in good grade patients. By contrast, poor grade patients (WFNS grades 4 and 5) require more advanced monitoring because stupor and coma reduce sensitivity to the effects of ischemia. Greater reliance on CT perfusion imaging, continuous electroencephalography, and invasive brain multimodality monitoring are potential strategies to improve situational awareness as it relates to detecting DCI. Pharmacologically-induced hypertension combined with volume is the established first-line therapy for DCI; a good clinical response with reversal of the presenting deficit occurs in 70 % of patients. Medically refractory DCI, defined as failure to respond adequately to these measures, should trigger step-wise escalation of rescue therapy. Level 1 rescue therapy consists of cardiac output optimization, hemoglobin optimization, and endovascular intervention, including angioplasty and intra-arterial vasodilator infusion. In highly refractory cases, level 2 rescue therapies are also considered, none of which have been validated. This review provides an overview of current state-of-the-art care for DCI management.
引用
收藏
相关论文
共 873 条
[21]  
Kassell N(1985)Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful? Ann Neurol 17 137-40
[22]  
Petruck KC(2011)Monitoring of volume status after subarachnoid hemorrhage Neurocrit Care 15 270-4
[23]  
West M(2011)Routine management of volume status after aneurysmal subarachnoid hemorrhage Neurocrit Care 15 275-80
[24]  
Mohr G(2014)Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid hemorrhage: a multicenter prospective cohort study Crit Care Med 42 1348-56
[25]  
Weir BK(1989)Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage Stroke 20 1156-61
[26]  
Benoit BG(2003)Quantification of lethargy in the neuro-ICU: the 60-second test Neurology 61 543-5
[27]  
Gentilli F(2011)Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage Neurocrit Care 14 162-7
[28]  
Disney LB(2011)Detection of cerebral compromise with multimodality monitoring in patients with subarachnoid hemorrhage Neurosurgery 69 53-63
[29]  
Khan MI(2014)Monitoring of cerebral blood flow and ischemia in the critically ill Neurocrit Care 21 121-8
[30]  
Grace M(2011)Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature Neurocrit Care 15 312-7